| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.28▲ | 1.31▲ | 1.31▲ | 1.30▲ | 2.15▼ |
| MA10 | 1.29▲ | 1.29▲ | 1.28▲ | 1.75▼ | 2.50▼ |
| MA20 | 1.24▲ | 1.25▲ | 1.30▲ | 2.28▼ | 6.86▼ |
| MA50 | 1.59▼ | 1.81▼ | 1.89▼ | 2.75▼ | 32.68▼ |
| MA100 | 2.14▼ | 2.34▼ | 2.34▼ | 8.38▼ | 299.80▼ |
| MA200 | 2.40▼ | 2.54▼ | 2.71▼ | 26.66▼ | 52,568.17▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.037▲ | 0.048▲ | 0.047▲ | -0.057▼ | 4.349▲ |
| RSI | 46.545▼ | 38.440▼ | 36.592▼ | 22.471▼ | 29.493▼ |
| STOCH | 54.662 | 79.937 | 79.937 | 12.636▼ | 9.515▼ |
| WILL %R | -14.286▲ | -14.286▲ | -6.452▲ | -84.848▼ | -97.888▼ |
| CCI | 93.333 | 54.453 | 58.333 | -94.715 | -84.936 |
|
Wednesday, July 22, 2026 06:00 AM
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for rare IF diseases, including MVID SAN FRANCISCO, CA / ...
|
|
Thursday, July 16, 2026 01:02 AM
Detailed price information for Jaguar Health Inc (JAGX-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, June 23, 2026 06:00 AM
Jaguar's recently completed pivotal effectiveness study of crofelemer for the treatment of CID in dogs demonstrates positive, statistically significant results SAN FRANCISCO, CA / ACCESS Newswire / ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/07/26 | 1.30 | 1.32 | 1.27 | 1.32 | 56,539 |
| 21/07/26 | 1.30 | 1.3596 | 1.23 | 1.26 | 45,024 |
| 20/07/26 | 1.27 | 1.28 | 1.17 | 1.265 | 64,737 |
| 17/07/26 | 1.27 | 1.42 | 1.02 | 1.30 | 314,627 |
| 16/07/26 | 1.95 | 1.975 | 1.2601 | 1.335 | 169,995 |
| 15/07/26 | 2.13 | 2.135 | 1.94 | 1.95 | 40,814 |
| 14/07/26 | 2.25 | 2.25 | 2.15 | 2.17 | 17,307 |
| 13/07/26 | 2.25 | 2.28 | 2.23 | 2.25 | 6,096 |
| 10/07/26 | 2.31 | 2.32 | 2.21 | 2.31 | 40,601 |
| 09/07/26 | 2.44 | 2.44 | 2.17 | 2.37 | 35,520 |
|
|
||||
|
|
||||
|
|